CSL Financials
| CSL Stock | 255.31 2.07 0.80% |
Operating Margin | PE Ratio 30.5706 | Profit Margin | Payout Ratio 1.0284 | EPS Estimate Current Year 6.5392 |
CSL | Select Account or Indicator |
Understanding current and past CSL Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CSL's financial statements are interrelated, with each one affecting the others. For example, an increase in CSL's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CSL's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CSL. Check CSL's Beneish M Score to see the likelihood of CSL's management manipulating its earnings.
CSL Stock Summary
CSL competes with KKR Credit, Commonwealth Bank, COG Financial, Magellan Financial, and Ambertech. CSL is entity of Australia. It is traded as Stock on AU exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Australia Stock View All |
| Exchange | Australian Securities Exchange |
| ISIN | AU000000CSL8 |
| Business Address | 655 Elizabeth Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.csl.com.au |
| Phone | 61 3 9389 1911 |
You should never invest in CSL without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CSL Stock, because this is throwing your money away. Analyzing the key information contained in CSL's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CSL Key Financial Ratios
CSL's financial ratios allow both analysts and investors to convert raw data from CSL's financial statements into concise, actionable information that can be used to evaluate the performance of CSL over time and compare it to other companies across industries.| Revenue | 14.69 B | ||||
| Gross Profit | 7.95 B | ||||
| EBITDA | 4.73 B | ||||
| Net Income | 4.03 B | ||||
| Total Asset | 38.02 B |
CSL Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 18.2B | 41.2B | 54.4B | 38.0B | 43.7B | 45.9B | |
| Other Current Liab | 2.6B | 3.1B | 4.6B | 3.0B | 3.4B | 3.6B | |
| Net Debt | 4.0B | (1.1B) | 16.0B | 10.5B | 12.1B | 12.7B | |
| Retained Earnings | 12.3B | 19.6B | 22.0B | 16.0B | 18.4B | 19.3B | |
| Accounts Payable | 392.7M | 591.8M | 820M | 867M | 997.1M | 1.0B | |
| Cash | 1.8B | 15.2B | 2.3B | 1.7B | 1.9B | 1.1B | |
| Net Receivables | 1.2B | 1.5B | 2.4B | 2.6B | 3.0B | 3.2B | |
| Good Will | 1.2B | 1.7B | 12.1B | 8.1B | 9.3B | 9.8B | |
| Inventory | 3.8B | 6.3B | 8.2B | 6.0B | 6.9B | 7.2B | |
| Other Current Assets | 214.4M | 208.1M | 340M | 506M | 581.9M | 611.0M | |
| Total Liab | 9.7B | 20.0B | 27.7B | 18.6B | 21.4B | 22.5B | |
| Total Current Assets | 7.4B | 23.9B | 13.9B | 10.8B | 12.4B | 13.0B | |
| Short Term Debt | 375.1M | 6.5B | 1.1B | 944M | 1.1B | 1.1B | |
| Other Assets | 401.8M | 558.6M | 0.75 | (17.6M) | (20.2M) | (19.2M) | |
| Intangible Assets | 2.7B | 3.8B | 24.7B | 8.3B | 9.5B | 10.0B | |
| Other Liab | 1.0B | 1.3B | 1.5B | 2.6B | 3.0B | 3.2B | |
| Long Term Debt | 4.2B | 3.9B | 9.6B | 9.7B | 11.1B | 11.7B | |
| Net Tangible Assets | 4.4B | 5.7B | 11.9B | (660M) | (759M) | (721.1M) | |
| Short Long Term Debt | 396M | 4.4B | 964M | 848M | 975.2M | 1.2B | |
| Long Term Debt Total | 5.3B | 5.2B | 11.2B | 11.2B | 12.9B | 13.6B |
CSL Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 170.8M | 142.8M | 408M | 420M | 483M | 507.2M | |
| Total Revenue | 10.3B | 10.5B | 13.2B | 14.7B | 16.9B | 17.7B | |
| Gross Profit | 5.8B | 5.7B | 6.7B | 7.6B | 8.7B | 9.1B | |
| Operating Income | 2.6B | 2.3B | 2.1B | 2.8B | 3.2B | 3.3B | |
| Ebit | 2.2B | 2.9B | 3.1B | 3.8B | 4.4B | 4.6B | |
| Research Development | 1.0B | 1.2B | 1.8B | 1.4B | 1.6B | 1.7B | |
| Ebitda | 2.7B | 3.5B | 3.9B | 4.7B | 5.4B | 5.7B | |
| Income Before Tax | 3.0B | 2.8B | 2.7B | 3.4B | 3.9B | 4.1B | |
| Net Income | 2.4B | 2.3B | 2.2B | 2.6B | 3.0B | 3.2B | |
| Income Tax Expense | 591.9M | 723.8M | 419M | 661M | 760.2M | 798.2M | |
| Cost Of Revenue | 4.6B | 4.8B | 6.5B | 7.1B | 8.2B | 8.6B | |
| Tax Provision | 588.1M | 524.9M | 419M | 661M | 760.2M | 510.3M | |
| Interest Income | 3.9M | 17.4M | 406M | 39M | 44.9M | 42.6M | |
| Net Interest Income | (166.9M) | (160.6M) | (406M) | (437M) | (393.3M) | (373.6M) |
CSL Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 578.8M | 8.6B | (8.8B) | 134M | 154.1M | 161.8M | |
| Free Cash Flow | 3.2B | 2.6B | 2.2B | 1.5B | 1.7B | 1.8B | |
| Depreciation | 533.8M | 647.4M | 1.1B | 1.4B | 1.6B | 1.7B | |
| Other Non Cash Items | 1.1B | (105.7M) | (477.4M) | 4.0B | 4.6B | 4.8B | |
| Dividends Paid | 958M | 1.0B | 1.2B | 1.3B | 1.5B | 1.5B | |
| Capital Expenditures | 1.7B | 1.2B | 1.7B | 1.3B | 1.4B | 1.5B | |
| Net Income | 3.2B | 3.3B | 3.3B | 4.0B | 4.6B | 4.9B | |
| End Period Cash Flow | 1.7B | 10.3B | 1.5B | 1.6B | 1.9B | 2.0B | |
| Change To Inventory | (490.4M) | (1.3B) | (1.4B) | (1.2B) | (1.1B) | (1.0B) | |
| Investments | (1.7B) | (387.7M) | (11.8B) | (1.3B) | (1.1B) | (1.2B) | |
| Net Borrowings | 198.8M | (496.7M) | 3.7B | 1.7B | 1.9B | 2.0B | |
| Change To Netincome | (11.5M) | 571.5M | 668.8M | 207M | 238.1M | 159.8M |
CSL Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSL's current stock value. Our valuation model uses many indicators to compare CSL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSL competition to find correlations between indicators driving CSL's intrinsic value. More Info.CSL is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSL is roughly 2.15 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSL's earnings, one of the primary drivers of an investment's value.CSL Systematic Risk
CSL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CSL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on CSL correlated with the market. If Beta is less than 0 CSL generally moves in the opposite direction as compared to the market. If CSL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CSL is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CSL is generally in the same direction as the market. If Beta > 1 CSL moves generally in the same direction as, but more than the movement of the benchmark.
CSL Total Assets Over Time
CSL July 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CSL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CSL. We use our internally-developed statistical techniques to arrive at the intrinsic value of CSL based on widely used predictive technical indicators. In general, we focus on analyzing CSL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CSL's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.23 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 5.55 | |||
| Value At Risk | (1.74) | |||
| Potential Upside | 2.4 |
Additional Tools for CSL Stock Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.